Treace Medical Concepts, Inc.
TMCI Nasdaq
SEC CIK 1630627
Follow Treace Medical Concepts
Weekly email: filings, results
Revenue, last quarter
$48.3M
−3.9% vs same quarter last year
Net income
−$12.6M
+22.9% vs same quarter last year
EPS, diluted
−$0.19
+26.9% vs same quarter last year
Operating cash flow
−$3.3M
+64.2% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $212.7M | −$59M |
| FY24 | $209.4M | −$55.7M |
| FY23 | $187.1M | −$50M |
| FY22 | $141.8M | −$43M |
| FY21 | $94.4M | −$20.6M |
| FY20 | $57.4M | −$3.7M |
| FY19 | $39.4M | −$4.3M |
| FY18 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 79.8% | −25.5% | −27.7% |
| FY24 | 80.4% | −26.6% | −26.6% |
| FY23 | 81.2% | −27.5% | −26.7% |
| FY22 | 82% | −24.6% | −30.3% |
| FY21 | 82.1% | −17.5% | −21.8% |
| FY20 | 78.3% | 1.5% | −6.4% |
| FY19 | 80.6% | −9% | −10.8% |
| FY18 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$29.5M |
| FY24 | −$48.8M |
| FY23 | −$46M |
| FY22 | −$45.5M |
| FY21 | −$19.9M |
| FY20 | −$5.6M |
| FY19 | −$8.9M |
| FY18 | - |
- Treace Medical Concepts
- Healthcare median
Show the numbers
| Year | Treace Medical Concepts | Healthcare median |
|---|---|---|
| FY25 | −27.7% | −30.6% |
| FY24 | −26.6% | −47% |
| FY23 | −26.7% | −58% |
| FY22 | −30.3% | −80.4% |
| FY21 | −21.8% | −71.9% |
| FY20 | −6.4% | −62.2% |
| FY19 | −10.8% | −46.3% |
| FY18 | - | −49.6% |